JT
Tamburini Bonnefoy, Jérôme
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| The E3 ubiquitin ligase MARCH5 promotes mitochondrial fusion and cell-cycle progression in acute myeloid leukemia | Blood advances |  | 2025 | 10 | 5 | ||
| Effectiveness of fractionated rituximab in preventing tumor lysis syndrome in aggressive B-cell lymphoma : Insights from real-life clinical practice | Cancer reports | | 2024 | 23 | 39 | ||
| Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation | Leukemia | | 2024 | 5 | 0 | ||
| Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models | Science translational medicine |  | 2024 | 108 | 0 | ||
| Selective haematological cancer eradication with preserved haematopoiesis | Nature | | 2024 | 69 | 22 | ||
| AMPK activation induces immunogenic cell death in AML | Blood advances | | 2023 | 33 | 6 | ||
| Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia | Blood advances | | 2023 | 85 | 24 | ||
| Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia | Leukemia | | 2023 | 50 | 7 | ||
| Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma | Cell death and disease | | 2023 | 266 | 57 | ||
| An in vivo CRISPR screening platform for prioritizing therapeutic targets in AML | Cancer discovery | | 2022 | 308 | 243 | ||
| RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia | Leukemia | | 2022 | 35 | 16 | ||
| T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients | Annals of oncology | | 2022 | 153 | 45 | ||
| AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia | Cancers | | 2021 | 155 | 61 | ||
| Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia | Science advances | | 2015 | 161 | 113 | ||
| The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation | Blood | | 2010 | 173 | 300 |
